Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spontaneous Preterm Birth Marker Test (SPBMT): Preterm Prediction Prospective Study

NCT03123926 is registered in ClinicalTrials.gov with Sprim Advanced Life Sciences as lead sponsor.

NCT NCT03123926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spontaneous Preterm Birth Marker Test (SPBMT): Preterm Prediction Prospective Study
Lead sponsor
Sprim Advanced Life Sciences
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2016
Completion date
December 31, 2018
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm delivery